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background: During atherogenesis, cytokines and oxLDL collude to fuel the proinflammatory milieu, all in a hypoxic setting. However, the precise 
contribution of hypoxia to the atherosclerotic state remains to be established. To elucidate the effects of hypoxia, we tested the hypothesis that 
inhibition of hypoxia-inducible factor (HIF)-1α, results in decreased macrophage (Mø) proinflammatory function and energetics.
Methods: Cultured Mø were challenged with either lipids, cytokines (GM, CK) or hypoxia. HIF-1α RNA silencing was performed while TNF-α 
and Fru-2,6-P2 served as markers of proinflammatory (M1) activation and glycolysis. ApoE KO mice underwent FDG-PET to quantify the effects of 
inhibiting HIF-1α on arterial inflammation.
results: Hypoxia alone resulted in minimal M1 activation (a). However, with the addition of oxLDL and cytokine, hypoxia potentiated action of 
these key mediators on Mø glycolysis (b) and M1 activation (a) via a mechanism dependent on HIF-1α. HIF-1α silencing reduced energetics (b) 
and M1 activation (c). In ApoE -/- mice, the in vitro findings translated to decreased arterial wall inflammation after HIF-1α interruption (d).
conclusion: These observations provide fundamental mechanistic insights into Mø biology at the crossroads between hypoxia, energetics and 
pro-inflammatory activation. Development of novel therapeutic agents targeting hypoxic sensing, which exerts its effect on both M1 activation and 
glycolysis, may alleviate atherosclerotic inflammation.
